HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: clinchem.2003.026088v1 50/5/836    most recent Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Strom, C. M. Articles by Jenison, R. D. Search for Related Content PubMed PubMed Citation Articles by Strom, C. M. Articles by Jenison, R. D. Related Collections Molecular Diagnostics and Genetics Automation and Analytical Techniques

Direct Visualization of Cystic Fibrosis Transmembrane Regulator Mutations in the Clinical Laboratory Setting

¹ Nichols Institute, Quest Diagnostics, San Juan Capistrano, CA.² Thermo Electron, Inc. Point of Care and Rapid Diagnostics, 331 S. 104th St., Louisville, CO 80027.

^aAuthor for correspondence. E-mail rob.jenison{at}thermo.com.

Background: The recommendation for population- based cystic fibrosis (CF) carrier screening by the American College of Medical Genetics for the 25 most prevalent mutations and 6 polymorphisms in the CF transmembrane regulatory gene has greatly increased clinical laboratory test volumes. We describe the development and technical validation of a DNA chip in a 96-well format to allow for high-throughput genotype analysis.

Methods: The CF Portrait^TM chip contains an 8 x 8 array of capture probes and controls to detect all requisite alleles. Single-tube multiplex PCR with 15 biotin-labeled primer pairs was used to amplify sequences containing all single-nucleotide polymorphisms to be interrogated. Detection of a thin-film signal created by hybridization of multiplex PCR-amplified DNA to complementary capture probes was performed with an automated image analysis instrument, NucleoSight^TM. Allele classification, data formatting, and uploading to a laboratory information system were fully automated.

Results: The described platform correctly classified all mutations and polymorphisms and can screen 1300 patient samples in a 10-h shift. Final validation was performed by two separate 1000-sample comparisons with Roche CF Gold line probe strips and the Applera CF OLA, Ver 3.0. The CF Portrait Biochip made no errors during this validation, whereas the Applera assay made seven miscalls of the IVS-8 5T/7T/9T polymorphism

Conclusions: The CF Portrait platform is an automated, high-throughput, DNA chip-based assay capable of accurately classifying all CF mutations in the recommended screening panel, including the IVS-8 5T/7T/9T polymorphism.

The following articles in journals at HighWire Press have cited this article:

				X. Lin, J. A. Flint, M. Azaro, T. Coradetti, W. M. Kopacka, D. L. Streck, Z. Wang, J. Dermody, and W. Mandecki Microtransponder-Based Multiplex Assay for Genotyping Cystic Fibrosis Clin. Chem., July 1, 2007; 53(7): 1372 - 1376. [Abstract] [Full Text] [PDF]

				C. M. Strom, R. Janeszco, F. Quan, S.-b. Wang, A. Buller, M. McGinniss, and W. Sun Technical Validation of a Tm Biosciences Luminex-Based Multiplex Assay for Detecting the American College of Medical Genetics Recommended Cystic Fibrosis Mutation Panel J. Mol. Diagn., July 1, 2006; 8(3): 371 - 375. [Abstract] [Full Text] [PDF]